-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TKzom+9r5KEpe6pVL8uBUlTxfNlImVdUdpuCZNT9XBWW+FjUVGqkB2HsEOUDJeZe qO/Cc+03JeXQMZuNYDf5SA== 9999999997-10-000751.txt : 20100127 9999999997-10-000751.hdr.sgml : 20100127 20100127150752 ACCESSION NUMBER: 9999999997-10-000751 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100127 DATE AS OF CHANGE: 20100127 20100127 20100127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 10550386 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@.#`U M,B]/(#@O12`S.#(P+TX@,2]4(#C2-6U6`[`(4!U? M(%2?%1"S,C#(ZD'$&7X#!!@``PH&Y`T*96YD%LP(#`@-C$R(#%LP(#`@-C$R(#O.,!>I"%B15VMOKF. MG7I;G2%6@0'-,,@R;7.015>BFN3?[_`BV4[=#-@G>WHK!K M1Q_RT;L\#X!"OAW1`'S\PY_03R#UQV0<07X8^;##_[Q47T\C!]S\;QQZE-`8 M\EN[D/]L!UY(LG%\>NP1WZ=C96X'3Z,OSN?E(I^Y7D3&SBVL7"\FB9.[)'`F MN5F=K<#],_]EY"4D'5^"(3<#I@8*;#6;?GY8Y`L7-T?*:+Y1WR6\XU,1J0*,)8]-:!M8X# M8[VXG:'%Y#?('V:3_!-.K%QHF,1GS*RQT5R=F'^<02\82C6S`L%DFL/]'&@6 MJF@$3F0!8Y*^Y2GU2?#]<>7`6AU\QVK6L&?XP(5DY;X6E=B]N.H0F(KF*)I" M*(7Q#3)P(/I_*<@BD,3+TJ"[,S@KVL? MO1%K(3*UH(2T)*)3DON7GH:]IZ'-1'"]((U#$I[[C)Z%CG31,G,&]\\\KZ'M MU@?M>.`3'^']_H!DD-(>P*5D&RAJ*(['BI=6N`2%Z^H-:^"A0RV":.T%-GP6 M\3IM:G*\85\[UDI>[Q0R>Y:L;A4ML84"C@W[QD77PJXI:FGD3$F4#B25/A8N M,B3%UHVP$*$4KBK(VDSYAM62%SK.%X5+\;L!7E_, MS5:C&9=]QFLV;V6@PY[+JMN@<-M&'$#N&]WS-90M2&)<"%6?_O%K1KH"Y M:`Y`?>]7V&*6;0`/OB^E6*/4-%$=P4^(;0D:X8=)B^WQ2GOI,\9W/A2M@6\8 M*MZB5-K-%M8OT.>2Z0S8+\)3A@RNAK$^[*+&+I),[@N)7[RU?#7.];RP<43U MT7U7-2@#\;4K*K[EK(6BQ>C66QO3"B>'`S/\L'CIB5\Z)$=J0)M2[1<-"EH7 MM9[HS="`SQO&-D*!A(Y*WT7O06@Q)Z6\ M@1@^DQ69$HCCX-%9/[J/3F2X9\2/X[,T&/"-N(_NC>9SR[_QOD*F0LDY)D%T M<.P79\,DLV[P&M.D%E(E[K%;8P^H M7F###7U*DKY[^(/NI@3:LA(MPZHA@"*4HME@N5"JHHRV0E-WLYV[PW7F#!7JGA(;KH8I39JQR@[R?@ZF(VEZ(;1%&,#^6^$=UN M;Y_U[;U2W?%6@?=/,Z)7<-DW)N>B3MD1O,).:ME-W MGKTC/(-RO66:#H256K%=H>_H3NY%P^7+^]ZC*]J\,>AETU'2G]^5WE1=@#B( M5+8>U$J*;\M,K>#KNE.I@5HI^A4;I8_J)T!C8>9/_=R:9B?386"BBB^`R:ND MP<^J)W,T>`.#LA_P[ZB<`6N;J>;0,^K43^S49M:JO=E5?H;6+!_](\``5-`F M7PH-"F5N9'-T2A4:6UE2A4:6UE7!E+T5X=$=3=&%T92]302!F86QS92]332`P+C`R/CX-96YD;V)J#3$@,"!O M8FH-/#PO3G5MFMC.60B/SX*/'@Z>&UP;65T M82!X;6QN#IX;7!T:STB061O8F4@6$U0 M($-O&UL M;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R M;W-O9G0@5V]R9"`M($=E;F5R97@@0FEO=&5C:&YO;&]G>2!#;W)P+B!/&%P34TZ26YS=&%N8V5)1#YU=6ED.F$X9#,V-68Y+3(P-C0M M-#$X,BTX,V4W+6(Y,S&%P34TZ26YS=&%N8V5)1#X*("`@ M("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO2!#;W)P+B!/ -----END PRIVACY-ENHANCED MESSAGE-----